Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anil Pareek

Showing results (51-60 of 63) with videos related to

Pageof 7
Sort By:
International Journal of Pharmaceutics|February 6, 2026
Nanoparticle-loaded microneedles as advanced transdermal systems for skin cancer managementAnil Pareek, Ekta Rawat, Kundan Kumar Chaubey, et al.
The Journal of Pain|February 1, 2011
Efficacy and safety of aceclofenac-cr and aceclofenac in the treatment of knee osteoarthritis: a 6-week, comparative, randomized, multicentric, double-blind studyAnil Pareek, Nitin Chandurkar, Anil Gupta, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology|June 18, 2010
Efficacy and safety of aceclofenac and drotaverine fixed-dose combination in the treatment of primary dysmenorrhoea: a double-blind, double-dummy, randomized comparative study with aceclofenacAnil Pareek, Nitin B Chandurkar, Rajeshree T Patil, et al.
International Journal of Pharmaceutics|June 27, 2025
pH-Sensitive hydrogels for breast cancer therapy: Targeted drug delivery and controlled release approachesAnil Pareek, Bhumi Bhatt, Vrutti Parmar, et al.
International Journal of Biological Macromolecules|September 9, 2025
Review of engineered magnetic chitosan nanoparticles for drug delivery: Advances, challenges, and future prospectsAnil Pareek, Glowi Alasiri, Yash Dudhwala, et al.
Current Medical Research and Opinion|August 19, 2007
Efficacy and safety of hydroxychloroquine sulphate in rheumatoid arthritis: a randomized, double-blind, placebo controlled clinical trial--an Indian experienceSiddharth Kumar Das, Anil Pareek, D S Mathur, et al.
International Journal of Pharmaceutics|August 29, 2025
Advances in nanotechnology-based thrombopoietic therapies: trends, challenges, and future directionsAnil Pareek, Glowi Alasiri, Sonam M Gandhi, et al.
Expert Opinion on Pharmacotherapy|April 8, 2011
Zaltoprofen, a noninferior alternative to diclofenac for the treatment of primary knee osteoarthritis -- a comparative evaluation of efficacy and safety in a 4-week, multicentric, randomized, double-blind, double-dummy trialAnil Pareek, Anil K Gupta, Nitin B Chandurkar, et al.
Nanomedicine (London, England)|February 11, 2017
Aceclofenac cocrystal nanoliposomes for rheumatoid arthritis with better dermatokinetic attributes: a preclinical studyGajanand Sharma, Mandeep Kaur Saini, Kanika Thakur, et al.
Malaria Research and Treatment|September 15, 2015
Sustained Release Formulation of Primaquine for Prevention of Relapse of Plasmodium vivax Malaria: A Randomized, Double-Blind, Comparative, Multicentric StudyAnil Pareek, Nitin Chandurkar, Nithya Gogtay, et al.
Pageof 7

Showing results (51-60 of 63) with videos related to

Sort By:
Pageof 7
International Journal of Pharmaceutics|February 6, 2026
Nanoparticle-loaded microneedles as advanced transdermal systems for skin cancer managementAnil Pareek, Ekta Rawat, Kundan Kumar Chaubey, et al.
The Journal of Pain|February 1, 2011
Efficacy and safety of aceclofenac-cr and aceclofenac in the treatment of knee osteoarthritis: a 6-week, comparative, randomized, multicentric, double-blind studyAnil Pareek, Nitin Chandurkar, Anil Gupta, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology|June 18, 2010
Efficacy and safety of aceclofenac and drotaverine fixed-dose combination in the treatment of primary dysmenorrhoea: a double-blind, double-dummy, randomized comparative study with aceclofenacAnil Pareek, Nitin B Chandurkar, Rajeshree T Patil, et al.
International Journal of Pharmaceutics|June 27, 2025
pH-Sensitive hydrogels for breast cancer therapy: Targeted drug delivery and controlled release approachesAnil Pareek, Bhumi Bhatt, Vrutti Parmar, et al.
International Journal of Biological Macromolecules|September 9, 2025
Review of engineered magnetic chitosan nanoparticles for drug delivery: Advances, challenges, and future prospectsAnil Pareek, Glowi Alasiri, Yash Dudhwala, et al.
Current Medical Research and Opinion|August 19, 2007
Efficacy and safety of hydroxychloroquine sulphate in rheumatoid arthritis: a randomized, double-blind, placebo controlled clinical trial--an Indian experienceSiddharth Kumar Das, Anil Pareek, D S Mathur, et al.
International Journal of Pharmaceutics|August 29, 2025
Advances in nanotechnology-based thrombopoietic therapies: trends, challenges, and future directionsAnil Pareek, Glowi Alasiri, Sonam M Gandhi, et al.
Expert Opinion on Pharmacotherapy|April 8, 2011
Zaltoprofen, a noninferior alternative to diclofenac for the treatment of primary knee osteoarthritis -- a comparative evaluation of efficacy and safety in a 4-week, multicentric, randomized, double-blind, double-dummy trialAnil Pareek, Anil K Gupta, Nitin B Chandurkar, et al.
Nanomedicine (London, England)|February 11, 2017
Aceclofenac cocrystal nanoliposomes for rheumatoid arthritis with better dermatokinetic attributes: a preclinical studyGajanand Sharma, Mandeep Kaur Saini, Kanika Thakur, et al.
Malaria Research and Treatment|September 15, 2015
Sustained Release Formulation of Primaquine for Prevention of Relapse of Plasmodium vivax Malaria: A Randomized, Double-Blind, Comparative, Multicentric StudyAnil Pareek, Nitin Chandurkar, Nithya Gogtay, et al.
Pageof 7